Immunology under the microscope: New frontiers

About this session

Immunology continues to unlock therapeutic possibilities across autoimmune, inflammatory, and immune-mediated conditions, making it a hotbed for innovation and capital deployment. This session explores emerging targets and novel modalities reshaping the landscape, examines what recent clinical data reveals about efficacy and differentiation, and discusses the deal dynamics and partnership strategies defining the space.

Speakers

• SP

  Sam Possemiers

  CEO · MRM Health

  Moderator

• RA

  Renee Aguiar-Lucander

  CEO · Hansa Biopharma

  Panelist

• SB

  Samuel Black

  Senior Director Global Business Development · Merck KGaA

  Panelist

• 

  Giulia Vestri

  Partner · Claris Ventures

  Panelist